Form 4 for HALO HALOZYME THERAPEUTICS, INC.
Accepted 2023-03-01 00:00:00 ET · period of report 2023-02-28 · accession 0001415889-23-003703 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-03-01 | 2023-02-28+ | HALO | Henderson Jeffrey William | Dir | S - Sale | $48.11 | -20.0K | 39.0K | -34% | -$962.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-28 | S | D | 10,000 | $48.51 | 49,045 | D | — | — | |
| 2 | Common | Common Stock | 2023-03-01 | S | D | 10,000 | $47.71 | 39,045 | D | — | — |